A clinical trial that had been testing the experimental gene therapy ABO-102 in people with advanced syndrome type A…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
A coalition of patient advocacy organizations has published a Global Roadmap for Sanfilippo Syndrome Therapies, in an effort to…
In a world-first, a team of scientists in Australia has developed a model of Sanfilippo syndrome type A in…
Music therapy may be beneficial for children with Sanfilippo syndrome, a small study in Spain illustrates. The study, “…
Any child who experiences developmental delay or intellectual disability by age 18 should undergo genetic sequencing as a first- or…
A clinical trial extension study involving 12 children with Sanfilippo syndrome type A was terminated early, after efficacy analyses found…
M041, an enzyme replacement therapy M6P Therapeutics (M6PT) is developing for Sanfilippo syndrome type B, can effectively be…
Two never-before-reported mutations were found in Sanfilippo syndrome type B patients, with one likely to be disease-causing, a recent study…
Eye Movement Desensitization and Reprocessing (EMDR) can help to ease symptoms of post-traumatic stress disorder (PTSD) in parents of children…
Treatment with ABO-102, an investigational gene therapy being developed by Abeona Therapeutics, normalized development in children with Sanfilippo…